NCT00749658 - Human Laboratory Study of Varenicline and Bupropion for Nicotine Dependence | Biotech Hunter

Enrollment

121

Participants

Timeline

Start Date

November 30, 2008

Primary Completion Date

September 30, 2010

Study Completion Date

September 30, 2010

Conditions

Nicotine DependenceNicotine Withdrawal

Interventions

DRUG

Bupropion

Form: tablet, Dosage, Frequency, Duration: Days 1-3, 150 mg, q.d., Days 4-11, 150 mg, b.i.d.

DRUG

Varenicline

Form: tablet, Dosage, Frequency, Duration: Days 1-3, .5 mg, q.d., Days 4-7, .5 mg, b.i.d., Days 8-11, 1 mg, b.i.d.

Trial Locations (1)

University of Minnesota, Tobacco Use Research Center, Minneapolis